UPDATE 1-Edwards Lifesciences lifts outlook on heart valve demand

Oct 26 (Reuters) - Edwards Lifesciences Corp reported better-than-expected third-quarter earnings and raised its full-year forecast on Monday, citing strong demand for its replacement heart valves that are implanted in minimally invasive procedures.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.